Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06896903 · ClinicalTrials.gov registry record · NA
Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing
A NA study of ANOCA - Angina With Non-obstructive Coronary Arteries and INOCA (Ischemia With Non Obstructive Coronary Artery Disease), sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06896903: Recruiting NA study of ANOCA - Angina With Non-obstructive Coronary Arteries and INOCA (Ischemia With Non Obstructive Coronary Artery Disease), sponsored by Baylor Research Institute.
NCT06896903 is a NA study of ANOCA - Angina With Non-obstructive Coronary Arteries and INOCA (Ischemia With Non Obstructive Coronary Artery Disease) that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06896903, a NA study of ANOCA - Angina With Non-obstructive Coronary Arteries and INOCA (Ischemia With Non Obstructive Coronary Artery Disease), is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-arm, multi-center, prospective study will assess the coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and determinants thereof (transit time, Pa, Pd) in patients before and after intracoronary nitroglycerine.
Primary Outcome
The primary outcome will be comparing the variables assessed by CRT with the primary outcome being CFR before and after nitroglycerin administration.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Coronary reactivity testing with and without nitrates
Study Locations (1)
Texas
- Baylor Scott & White The Heart Hospital - Plano - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-05-21 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT06896903 shows while recruiting
NCT06896903 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with ANOCA - Angina With Non-obstructive Coronary Arteries appearing as the primary indexed condition, and to 1 intervention - of which Coronary reactivity testing with and without nitrates is the first listed.
NCT06896903 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06896903 about?
NCT06896903 is a clinical study titled "Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing". This single-arm, multi-center, prospective study will assess the coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and determinants thereof (transit time, Pa, Pd) in patients before and after intracoronary nitroglycerine.
What is the current status of trial NCT06896903?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-05-21. Estimated completion is 2026-06-01.
What conditions does trial NCT06896903 study?
This clinical trial studies the following conditions: ANOCA - Angina With Non-obstructive Coronary Arteries, INOCA (Ischemia With Non Obstructive Coronary Artery Disease).
What interventions are being tested in trial NCT06896903?
The interventions under investigation include: Coronary reactivity testing with and without nitrates (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06896903?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06896903 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06896903's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI